Company
About the company
Grifols UK supplies plasma-derived medicines, transfusion technologies and related healthcare products and services. Its customers include hospitals, blood banks, clinical laboratories and healthcare professionals. The UK operation is based in Cambridge and forms part of an international healthcare group active in plasma therapies, diagnostic systems and hospital pharmacy services.
Company statement
Carbon claim
Grifols UK commits to net-zero emissions by 2050 and reports an 18% reduction against its 2022 emissions baseline from completed initiatives.
A short summary of publicly available information. We have not verified the carbon claim.
Read the public source